Table 1 Association between JMJD6 expression and clinicopathological variables of ovarian cancer patients
From: Jumonji domain-containing 6 (JMJD6) identified as a potential therapeutic target in ovarian cancer
Variables | No. | JMJD6 protein expression | P value | |
---|---|---|---|---|
Low | High | |||
Age | 146 | 90 | 56 | 0.026 |
 <60 | 111 | 74 | 37 | |
 ≥60 | 35 | 16 | 19 | |
Tumor diameter | 146 | 90 | 56 | 0.140 |
 <10 cm | 58 | 40 | 18 | |
 ≥10 cm | 88 | 50 | 38 | |
Pathological grade | 118 | 69 | 51 | 0.136 |
 1 | 13 | 10 | 3 | |
 2–3 | 105 | 58 | 47 | |
Clinical stage | 146 | 90 | 56 | <0.001 |
 I–II | 45 | 38 | 7 | |
 III–IV | 101 | 52 | 49 | |
pT status | 146 | 90 | 56 | 0.015 |
 pT 1 | 9 | 9 | 0 | |
 pT 2–3 | 137 | 81 | 56 | |
pN status | 146 | 90 | 56 | 0.003 |
 pN 0 | 106 | 73 | 33 | |
 pN 1 | 40 | 17 | 23 | |
pM status | 146 | 90 | 56 | 0.765 |
 pM 0 | 114 | 71 | 43 | |
 pM 1 | 32 | 19 | 13 | |
Relapse | 146 | 90 | 56 | 0.002 |
 Yes | 116 | 64 | 52 | |
 No | 30 | 26 | 4 |